343 related articles for article (PubMed ID: 9987207)
1. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
Ramasubbu R
J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
[TBL] [Abstract][Full Text] [Related]
2. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.
Jacobsen FM
J Clin Psychiatry; 1992 Apr; 53(4):119-22. PubMed ID: 1564046
[TBL] [Abstract][Full Text] [Related]
4. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
Walker PW; Cole JO; Gardner EA; Hughes AR; Johnston JA; Batey SR; Lineberry CG
J Clin Psychiatry; 1993 Dec; 54(12):459-65. PubMed ID: 8276736
[TBL] [Abstract][Full Text] [Related]
5. [Antidepressants and sexual stimulation: the correlation].
Chebili S; Abaoub A; Mezouane B; Le Goff JF
Encephale; 1998; 24(3):180-4. PubMed ID: 9696909
[TBL] [Abstract][Full Text] [Related]
6. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
Montejo AL; Llorca G; Izquierdo JA; Rico-Villademoros F
J Clin Psychiatry; 2001; 62 Suppl 3():10-21. PubMed ID: 11229449
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement.
Stassen HH; Angst J; Delini-Stula A
Pharmacopsychiatry; 1999 Mar; 32(2):56-60. PubMed ID: 10333163
[TBL] [Abstract][Full Text] [Related]
8. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
Duarte A; Mikkelsen H; Delini-Stula A
J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
[TBL] [Abstract][Full Text] [Related]
9. Moclobemide versus fluoxetine for a major depressive episode.
Reynaert C; Parent M; Mirel J; Janne P; Haazen L
Psychopharmacology (Berl); 1995 Mar; 118(2):183-7. PubMed ID: 7617806
[TBL] [Abstract][Full Text] [Related]
10. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.
Clayton AH; Zajecka J; Ferguson JM; Filipiak-Reisner JK; Brown MT; Schwartz GE
Int Clin Psychopharmacol; 2003 May; 18(3):151-6. PubMed ID: 12702894
[TBL] [Abstract][Full Text] [Related]
11. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine in the treatment of depression in Asian (Chinese and Indian) patients in Singapore.
Tsoi WF; Tan CT; Kok LP
Singapore Med J; 1995 Aug; 36(4):397-9. PubMed ID: 8919155
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine-induced sexual dysfunction.
Herman JB; Brotman AW; Pollack MH; Falk WE; Biederman J; Rosenbaum JF
J Clin Psychiatry; 1990 Jan; 51(1):25-7. PubMed ID: 2295587
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
Becker T; Struck M; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
[TBL] [Abstract][Full Text] [Related]
15. Sexual dysfunction during antidepressant treatment.
Balon R; Yeragani VK; Pohl R; Ramesh C
J Clin Psychiatry; 1993 Jun; 54(6):209-12. PubMed ID: 8331089
[TBL] [Abstract][Full Text] [Related]
16. The safety profile of nefazodone.
Robinson DS; Roberts DL; Smith JM; Stringfellow JC; Kaplita SB; Seminara JA; Marcus RN
J Clin Psychiatry; 1996; 57 Suppl 2():31-8. PubMed ID: 8626361
[TBL] [Abstract][Full Text] [Related]
17. Switching to tianeptine in patients with antidepressant-induced sexual dysfunction.
Atmaca M; Kuloglu M; Tezcan E; Buyukbayram A
Hum Psychopharmacol; 2003 Jun; 18(4):277-80. PubMed ID: 12766932
[TBL] [Abstract][Full Text] [Related]
18. Moclobemide versus fluoxetine for major depressive episodes.
Geerts S; Bruynooghe F; De Cuyper H; Demeulemeester F; Haazen L
Clin Neuropharmacol; 1994; 17 Suppl 1():S50-7. PubMed ID: 7954484
[TBL] [Abstract][Full Text] [Related]
19. [Various forms of risk factors of antidepressive agents for influencing sexual functions. Moclobemid is first choice for the therapy of sexually active patients with depression].
Fortschr Neurol Psychiatr; 1999 May; 67(5 Suppl Unterschie):1-4. PubMed ID: 10368779
[No Abstract] [Full Text] [Related]
20. Preliminary experience with moclobemide for the treatment of depressive disorders in Malaysia.
Indran SK
Singapore Med J; 1995 Apr; 36(2):189-90. PubMed ID: 7676265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
